01
The problem
iCTS needed an end-to-end platform that could bridge global clinical-trial standards with local site, ethics, enrolment, and compliance realities.
02
Scope of work
- Trial, site, investigator, patient, and research-study management.
- IRB, ethics, and DSMB workflows with compliance and audit trails.
- Product discovery, engineering, quality assurance, and cloud delivery.
03
Result recorded
By 17 July 2026, Phase 1 registry engineering was active while product and design teams worked ahead on Phases 2 and 3. Outcome metrics remain pending until delivery and adoption mature.